This is a preview of subscription content, log in via an institution to check access.
Notes
Costs (2010 values) were from a third-party payer perspective and included those for drugs, physician and physiotherapist visits, diagnostic and laboratory testing, and in-patient stay.
Reference
Ekwunife OI, et al. Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis. Cost Effectiveness and Resource Allocation 11: No. 2, 23 Jan 2013. Available from: URL: http://dx.doi.org/10.1186/1478-7547-11-2
Rights and permissions
About this article
Cite this article
Thiazide diuretics top of the class in Nigeria. PharmacoEcon Outcomes News 671, 7 (2013). https://doi.org/10.1007/s40274-013-0135-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0135-x